Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

Data as of Oct 20
 +0.03 / +0.02%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products. The company has a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded on January 18, 2012 and is headquartered in Dublin, Ireland.

Contact Information

Jazz Pharmaceuticals Plc
Connaught House
Dublin Dublin 4
P:(531) 634-7800
Investor Relations:
(531) 634-7887



Mutual fund holders59.76%
Other institutional28.51%
Individual stakeholders19.14%

Top Executives

Bruce C. CozaddChairman & Chief Executive Officer
Russell J. CoxChief Operating Officer & Executive Vice President
Matthew P. YoungChief Financial Officer & Senior Vice President
Jeffrey K. TobiasChief Medical Officer, EVP-Research & Development
Mark G. EllerSenior VP-Research & Clinical Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.